about the author

Amber Tong

amber@endpointsnews.com @AmberTongPW
Amber Tong on LinkedIn

author articles

'U snooze u lose': Judg­ment day for $100M biotech in­sid­er trad­ing scheme looms as son of for­mer Ari­ad di­rec­tor stands ...

6 years ago
People

Mer­ck dives deep­er in­to KRAS, team­ing up with Tai­ho, As­tex to de­vel­op small mol­e­cule drugs

6 years ago
Deals

FDA rushed to ap­prove new drugs in 2019, some­times way ahead of sched­ule. Could that be dan­ger­ous?

6 years ago
FDA+

Bank­rupt uBio­me sells off patents, da­ta for $7M; J&J buys op­tions on Pul­ma­trix's lung can­cer drugs

6 years ago
News Briefing

Of­fer­ing much need­ed re­lief for Wood­ford-as­so­ci­at­ed funds, se­quenc­ing uni­corn Ox­ford Nanopore rais­es $105.9M in new ...

6 years ago
Financing

BeiGene scores first Chi­na OK with PD-1 — to be man­u­fac­tured by Boehringer In­gel­heim

6 years ago
China
Pharma

Chi­na green­lights home­grown pneu­mo­coc­cal, HPV vac­cines for the mar­ket — break­ing grips by Pfiz­er, Mer­ck

6 years ago
China
FDA+

Chi­nese court sen­tences Jiankui He to 3 years in jail — and con­firms birth of 3rd CRISPR ba­by

6 years ago
China
Cell/Gene Tx

Bank­ing on Shang­hai's biotech boom, this Eli Lil­ly-backed play­er grabs $100M to push next-gen I/O ther­a­pies

6 years ago
Financing
Startups

Sanofi's hur­ried, $2.5B pur­suit for Syn­thorx drove buy­out price high and left keen ri­val sore­ly dis­ap­point­ed

6 years ago
Deals

J&J rounds out the year with twin buy­outs, gain­ing con­trol of de­liv­ery and sur­gi­cal ro­bot­ics tech

6 years ago
Deals

FDA slams GSK's month­ly HIV in­jectable with CRL, cit­ing man­u­fac­tur­ing is­sues

6 years ago
FDA+

HH­MI dis­crim­i­nat­ed against two Asian Amer­i­can women in­ves­ti­ga­tors, law­suits al­lege

6 years ago
People
Discovery

Bio­gen makes cau­tious bet on dry AMD as part­ner Cat­a­lyst Bio moves an­ti-C3 drug to­ward the clin­ic

6 years ago
Deals

NIH-di­rect­ed purge of re­searchers with Chi­na ties sweeps up Mof­fitt CEO Alan List, col­leagues

6 years ago
China
Discovery

Flag­ship bankrolls quest to cre­ate gene ther­a­py 2.0, with new vi­ral de­liv­ery tech in hand

6 years ago
Financing
Startups

Seat­tle Ge­net­ics gets ready to launch its sec­ond ADC af­ter scor­ing blad­der can­cer OK with part­ner Astel­las

6 years ago
R&D
FDA+

Canaan backs Pathios' search for small mol­e­cule drugs that hit 'or­phan' GCPR

6 years ago
Financing
Startups

FTC calls out Il­lu­mi­na as 'mo­nop­o­list,' moves to block $1.2B ac­qui­si­tion of PacBio

6 years ago
Deals

Bio­haven cel­e­brates PhII/III win for in­tranasal CGRP mi­graine drug amid oral race with Al­ler­gan

6 years ago
R&D

What uni­fies Hunt­ing­ton's, spin­ocere­bel­lar atax­ia and my­oton­ic dy­s­tro­phy? Ness Berming­ham's new start­up looks to drug ...

6 years ago
Financing
Startups

Wave's Duchenne pro­gram comes to a screech­ing halt — now all eyes will be on Hunt­ing­ton's

6 years ago
R&D

UK an­titrust watch­dog clears Roche/Spark deal — but what is the FTC think­ing?

6 years ago
Deals
Cell/Gene Tx

Roche's triplet in­volv­ing Tecen­triq clears the PFS bar for melanoma when added to BRAF/MEK com­bo

6 years ago
R&D
Pharma
First page Previous page 84858687888990 Next page Last page
A service from the Financial Times